CTI BioPharma
CTIC
#5622
Rank
NZ$2.07 B
Marketcap
NZ$15.73
Share price
0.00%
Change (1 day)
33.17%
Change (1 year)

Earnings for CTI BioPharma (CTIC)

Earnings in 2023 (TTM): -NZ$0.12 Billion

According to CTI BioPharma 's latest financial reports the company's current earnings are NZ$75.76 Million. In 2022 the company made an earning of -NZ$0.17 Billion, an increase over its 2021 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for CTI BioPharma from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$0.12 Billion-29.74%
2022 -NZ$0.17 Billion-5.02%
2021 -NZ$0.17 Billion86.67%
2020 -NZ$90.8 Million31.05%
2019 -NZ$69.28 Million36.36%
2018 -NZ$50.81 Million-28.11%
2017 -NZ$70.68 Million-22.89%
2016 -NZ$91.67 Million-56.15%
2015 -NZ$0.21 Billion28.16%
2014 -NZ$0.17 Billion116.37%
2013 -NZ$75.39 Million-57.17%
2012 -NZ$0.18 Billion62.39%
2011 -NZ$0.11 Billion-16.23%
2010 -NZ$0.13 Billion-20.68%
2009 -NZ$0.17 Billion22.01%
2008 -NZ$0.14 Billion-28.59%
2007 -NZ$0.19 Billion10.34%
2006 -NZ$0.17 Billion118.07%
2005 -NZ$77.82 Million-70.71%
2004 -NZ$0.27 Billion25.18%
2003 -NZ$0.22 Billion21.81%
2002 -NZ$0.18 Billion20.55%
2001 -NZ$0.15 Billion50.36%
2000 -NZ$96.12 Million49.26%
1999 -NZ$64.4 Million35.27%
1998 -NZ$47.61 Million7%
1997 -NZ$44.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.27 B-12,006.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.90 B-11,701.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$2.74 B-2,393.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.47 Billion 289.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.95 B-32,601.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.06 B-2,659.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$28.42 B-23,813.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland